Protagenic Therapeutics, Inc. (PTIXW) Ownership

$0.06

$0.01 (32.89%)
Last update: 03:54 PM EST
Day's range
$0.06
Day's range
$0.06

Protagenic Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WARBERG ASSET MANAGEMENT LLC 05/09/2025 170.24 K $1.28 K   0.00% 32.54%
CLEAR STREET LLC 05/15/2025 100.00 K $750   100.00% 19.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 50.18 K $376   -25.29% 9.59%
GTS SECURITIES LLC 05/15/2025 25.30 K $202   -0.39% 4.84%
UBS GROUP AG 05/13/2025 3.00 K $21   733.33% 0.57%
TWO SIGMA SECURITIES, LLC 05/15/2025 0 $0   -100.00% 0.00%

Protagenic Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 6 institutional investors and hedge funds held shares of Protagenic Therapeutics, Inc.. The most heavily invested institutionals were:

Warberg Asset Management LLC: 170,242

CLEAR STREET LLC: 100,000

SUSQUEHANNA INTERNATIONAL GROUP, LLP: 50,184

GTS SECURITIES LLC: 25,300

UBS Group AG: 3,000

TWO SIGMA SECURITIES, LLC: 0

66.65% of Protagenic Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 348.73 K shares in the last 24 months. This purchase volume represents approximately $20.92 K in transactions.